58 results on '"Kato, Takahiro"'
Search Results
2. Effects of COVID-19 on Mental Health in Business: Increasing the Hikikomori-Like Workers in Japan
3. Urban Mental Health in the Twenty-First Century
4. Modulating Microglial Activation As a Possible Therapeutic Target for Depression
5. Antidepressants Modulate Microglia Beyond the Neurotransmitters Doctrine of Mood Disorders
6. Loneliness and Single-Person Households: Issues of Kodokushi and Hikikomori in Japan
7. Neurodevelopmental and Neuropsychiatric Disorders
8. Manipulability Enhancement by an Impedance Parameter Tuning for a Remote Ultrasound Diagnostic System
9. Therapeutic Potential of Melatonin in Combination with Other Drugs Against Neurodegeneration
10. Melatonin, Sleep, Circadian Rhythm, and Mood Disorders
11. Melatonin, a Neuroprotective Agent: Relevance for Stress-Induced Neuropsychiatric Disorders
12. Melatonin Supplementation in Neurodegenerative Diseases: Current Status
13. Melatonin and Melatonin Receptors in Neuroprotection
14. S-Adenosyl-L-Methionine for Major Depressive Disorder
15. Melatonin and Other Neuroprotective Agents Target Molecular Mechanisms of Disease in Amyotrophic Lateral Sclerosis
16. Prolactin and Somatostatin Responses to Antidepressant Therapy
17. The Role of Antiepileptic Drugs in Bipolar Depression
18. Melatonin: Basic and Clinical Aspects
19. Effects of Methylphenidate and Atomoxetine on Development of the Brain
20. Antidepressant Drugs and Phosphodiesterases
21. Nitric Oxide Signaling in Depression and Antidepressant Action
22. The Role of Arrestins in the Neuroprotective Effects of Antidepressant Drugs
23. Corticotropin-Releasing Factor Receptors as a Potential Target in the Developments of Antidepressant Drugs
24. The Glutamate mGluR5 Receptor as a Pharmacological Target to Enhance Cognitive Function: Emerging Evidence from Psychosis Models
25. Acetylcholinergic Nicotinic Receptors as Pharmacological Targets for Cognitive Enhancement: Emerging Evidence from Psychosis Populations
26. Antidepressant and Anticonvulsant Drugs as Adjuvant Analgesics in Chronic Pain
27. Neuroimaging of the Pineal Gland: Focus on Primary Insomnia
28. Ketamine: The Glutamatergic Antidepressant and Its Efficacy
29. The Role of Vasopressin in Anxiety and Depression
30. Targeting Opioid Receptors for Innovative Antidepressant Therapies: Rediscovering the Opioid Cure
31. Melatonin as a Novel Therapeutic Agent Against Chemical Warfare Agents
32. Genetic Polymorphisms of Cytochrome P450 and Antidepressants
33. Pharmacogenomics of Antidepressant Drugs
34. Brain-Derived Neurotrophic Factor (BDNF): TrkB Signaling in Depression – Biomarker and Novel Therapeutic Target
35. Neurobiology and Pharmacological Prevention of Suicide in Mood Disorders
36. Antidepressant Medications and Suicide Risk: What Was the Impact of FDA Warning?
37. Antidepressant Efficacy of Escitalopram in Major Depressive Disorder
38. Bibliometric Study of Scientific Research on Melatonin During the Last 25 Years
39. Neurocognitive Deficit in Bipolar Disorders
40. Depression: Correlations with Thyroid Hormones in Major Depressive Disorder
41. Antidepressant Drugs in Elderly
42. Understanding the Biologically Adaptive Side of Mood Disorders: A Focus on Affective Temperaments
43. History of the Discovery of Antidepressant Drugs
44. Combination Strategies in Treatment-Resistant Depression
45. Sleep Abnormalities as a Diagnostic Tool for Major Depressive Disorder
46. History of Pineal Gland as Neuroendocrine Organ and the Discovery of Melatonin
47. Circadian Clock Genes and Mood Disorders
48. Chronobiology of Mood Disorders
49. Bipolar Disorders and Biological Rhythms
50. Agomelatine, Melatonin and Depression
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.